Sophie is a Consultant at Avalere Health with over nine years of experience in health economics and market access across the pharmaceutical consulting and medical technology sectors.
At Avalere Health, she has led projects involving strategic landscape assessments and primary research with payers and key opinion leaders (KOLs). She has expertise in European real-world evidence (RWE) data, health economic evaluations, development of value-based communication tools, and systematic literature reviews to support strategic market access decisions and HTA submissions. Sophie has worked across multiple therapeutic areas, including diabetes, oncology, eye diseases, cardiovascular diseases, and neuromodulation treatments. She holds an MSc in Health Economics from the University of York (UK) and a BSc in Accounting and Finance from the University of Macedonia (Greece).